Clinical ResearchVascular DiseasePeripheral Arterial Disease and Progression of Coronary Atherosclerosis
Key Words
Abbreviations and Acronyms
Cited by (0)
Dr. Nissen has received research support to perform clinical trials through the Cleveland Clinic Coordinating Center for Clinical Research from Pfizer, AstraZeneca, Novartis, Roche, Daiichi-Sankyo, Takeda, Sanofi-Aventis, Resverlogix, and Eli Lilly; and is a consultant/advisor for many pharmaceutical companies but requires them to donate all honoraria or consulting fees directly to charity so that he receives neither income nor a tax deduction. Dr. Nicholls receives honoraria from AstraZeneca, Merck, and Takeda Roche; is a consultant to Pfizer, AstraZeneca, Merck, Takeda, Anthera, and NovoNordisk; and receives research support from AstraZeneca, Novartis, Resverlogix, Eli Lilly, and Anthera. All other authors have reported that they have no relationships to disclose.